Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.150
+0.020 (0.94%)
At close: Sep 5, 2025, 4:00 PM
2.170
+0.020 (0.93%)
After-hours: Sep 5, 2025, 7:35 PM EDT

Daré Bioscience Statistics

Total Valuation

Daré Bioscience has a market cap or net worth of $28.34 million. The enterprise value is $26.33 million.

Market Cap28.34M
Enterprise Value 26.33M

Important Dates

The last earnings date was Thursday, August 14, 2025, after market close.

Earnings Date Aug 14, 2025
Ex-Dividend Date n/a

Share Statistics

Daré Bioscience has 13.18 million shares outstanding. The number of shares has increased by 10.12% in one year.

Current Share Class 13.18M
Shares Outstanding 13.18M
Shares Change (YoY) +10.12%
Shares Change (QoQ) +1.28%
Owned by Insiders (%) 1.05%
Owned by Institutions (%) 6.86%
Float 13.04M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio -1,600.81
Forward PS 2.93
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.34

Current Ratio 0.34
Quick Ratio 0.27
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -63.13%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 296.05%
Revenue Per Employee n/a
Profits Per Employee -$808,856
Employee Count23
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -40.11% in the last 52 weeks. The beta is 1.14, so Daré Bioscience's price volatility has been higher than the market average.

Beta (5Y) 1.14
52-Week Price Change -40.11%
50-Day Moving Average 2.32
200-Day Moving Average 2.88
Relative Strength Index (RSI) 48.66
Average Volume (20 Days) 182,162

Short Selling Information

The latest short interest is 261,127, so 1.98% of the outstanding shares have been sold short.

Short Interest 261,127
Short Previous Month 229,708
Short % of Shares Out 1.98%
Short % of Float 2.00%
Short Ratio (days to cover) 0.41

Income Statement

In the last 12 months, Daré Bioscience had revenue of -$17,701 and -$18.60 million in losses. Loss per share was -$2.14.

Revenue-17,701
Gross Profit -14.32M
Operating Income -18.48M
Pretax Income -28.87M
Net Income -18.60M
EBITDA -17.84M
EBIT -18.48M
Loss Per Share -$2.14
Full Income Statement

Balance Sheet

The company has $5.04 million in cash and $3.03 million in debt, giving a net cash position of $2.00 million or $0.15 per share.

Cash & Cash Equivalents 5.04M
Total Debt 3.03M
Net Cash 2.00M
Net Cash Per Share $0.15
Equity (Book Value) -12.73M
Book Value Per Share -1.41
Working Capital -12.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.59 million and capital expenditures -$284,459, giving a free cash flow of -$11.87 million.

Operating Cash Flow -11.59M
Capital Expenditures -284,459
Free Cash Flow -11.87M
FCF Per Share -$0.90
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin 104,392.20%
Pretax Margin 105,099.65%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Daré Bioscience does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -10.12%
Shareholder Yield -10.12%
Earnings Yield -65.65%
FCF Yield -41.89%

Analyst Forecast

The average price target for Daré Bioscience is $10.00, which is 365.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 365.12%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 681.78%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 1, 2024. It was a reverse split with a ratio of 1:12.

Last Split Date Jul 1, 2024
Split Type Reverse
Split Ratio 1:12

Scores

Daré Bioscience has an Altman Z-Score of -25.03 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -25.03
Piotroski F-Score 2